I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert whose extensive experience in research and development, paired with a passion for technology and innovation, has positioned him at the forefront of transformative advancements in the industry. Today, we’ll dive into the
In a significant stride toward combating advanced lung cancer, the U.S. Food and Drug Administration has granted Fast Track designation to a promising new therapy known as AVZO-1418, also referred to as DB-1418. This innovative treatment targets patients with unresectable, locally advanced, or
Today, we’re thrilled to sit down with Ivan Kairatov, a biopharma expert with extensive experience in research and development, and a deep understanding of technological innovation in the industry. Ivan has been closely following the groundbreaking advancements in malaria treatment, including the
Diving into the forefront of cancer immunotherapy, we’re thrilled to speak with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development. Ivan’s deep knowledge of technological innovation in the industry has positioned him as a leading voice in the fight
In a groundbreaking stride toward transforming prostate cancer care, researchers have uncovered a potential game-changer that could redefine how this prevalent disease is tackled, offering new hope to millions of men worldwide. Prostate cancer remains the second most common cancer among men
What happens when a disease, hidden in plain sight, claims over a million lives each year, yet remains stubbornly resistant to modern medicine? Tuberculosis (TB), caused by Mycobacterium tuberculosis , stands as one of humanity's oldest and deadliest foes, striking hardest in vulnerable communities
